Excellence in Diagnosis and Efficient Turn Around Time
Albert K. Ho , MD, PhD
Anatomic Pathology, Clinical Pathology and Hematology/Hematopathology
Anatomic and Clinical Pathology
Hematopathology, University of Utah, Salt Lake City, UT
Surgical Pathology, Barnes-Jewish Hospital, Washington University, St. Louis, MO
Anatomic and Clinical Pathology, Barnes-Jewish Hospital, Washington University, St. Louis, MO
Washington University School of Medicine, St. Louis, MO
Qu K, Pan Q, Zhang X, Rodriguez L, Zhang K, Li H, Ho A, Sanders H, Sferruzza A, Cheng S, Nguyen D, Jones D, Waldman F. (2013) Detection of BRAF V600 mutations in metastatic melanoma: Comparison of the Cobas 4800 and Sanger sequencing assays. Journal of Molecular Diagnostics 15(6):790-5.
Dai Z, Kelly JC, Meloni-Ehrig A, Slovak ML, Boles D, Christacos NC, Bryke CR, Schonberg SA, Otani-Rosa J, Pan Q, Ho AK, Sanders HR, Zhang ZJ, Jones D, Mowrey PN. (2012) Incidence and patterns of ALK FISH abnormalities seen in a large unselected series of lung carcinomas. Molecular Cytogenetics 5(1):44-9.
Ho AK, Teman CJ, Smith GP, Nightingale DR, Miles RR. (2011) Composite mantle cell and diffuse large B-cell lymphoma: report of two cases. International Journal of Surgical Pathology 19(5):643-8.
Schumacher JA, Szankasi P, Bahler DW, Ho AK, Kelley TW. (2011) A pyrosequencing-based test for detection and relative quantification of the BCR-ABL T315I point mutation. Journal of Clinical Pathology 64(7):618-25.
Szankasi P, Ho AK, Bahler DW, Efimova O, Kelley TW. (2011) Combined testing for CCAAT/enhancer-binding protein alpha (CEBPA) mutations and promoter methylation in acute myeloid leukemia demonstrates shared phenotypic features. Leukemia Research 35(2):200-7.
Ho AK, Hill S, Preobrazhensky SN, Miller ME, Chen Z, Bahler DW. (2009) Small B-cell neoplasms with typical mantle cell lymphoma immunophenotypes often include chronic lymphocytic leukemias. American Journal of Clinical Pathology 131:27-32.
Liapis H, Ho AK, Brown D, Mindel G, Gleich G. (2005) Thrombotic microangiopathy associated with the hypereosinophilic syndrome. Kidney International 67(5):1806-11.
Sondermann H, Ho AK, Listenberger LL, Siegers K, Moarefi I, Wente SR, Hartl FU, Young JC. (2002) Prediction of novel Bag-1 homologs based on structure/function analysis identifies Snl1p as an Hsp70 co-chaperone in Saccharomyces cerevisiae. Journal of Biological Chemistry 277:33220-7.
Ho AK, Shen TX, Ryan KJ, Kiseleva E, Levy MA, Allen TD, Wente SR. (2000) Assembly and preferential localization of Nup116p on the cytoplasmic face of the nuclear pore complex by interaction with Nup82p. Molecular and Cellular Biology 20:5736-48.
Ho AK, Raczniak GA, Ives EB, Wente SR. (1998) The integral membrane protein Snl1p is genetically linked to yeast nuclear pore complex function. Molecular Biology of the Cell 9:355-73.
Ho, Albert and Jones, Dan. “Chapter 44: Myeloproliferative Neoplasms and Myelodysplastic Syndromes.” Molecular Pathology in Clinical Practice, 2nd Edition. Ed. Debra G.B. Leonard. Switzerland: Springer, 2016. Pages 615-26.
Jones D, Ho AK, Billouin-Frazier S, Wang Y. (2014) Molecular monitoring of acute myeloid leukemia: patterns at presentation and post-therapy. Blood 124:2366.
Wang Y, Ho AK, Pan Q, Racke FK, Jones D. (2014) In-frame exon 9 CALR deletions co-occur with other alterations in the JAK-STAT pathway in myeloproliferative neoplasms. Blood 124:4588.
Wang Y, Ho AK, Billouin-Frazier S, Pan Q, Jones D. (2013) Additive value of high-throughput sequencing of myeloid-associated gene mutations in diagnosing myeloproliferative neoplasms. Modern Pathology 26(S2):365A.
Qu KZ, Pan Q, Zhang X, Rodriguez L, Uyeji J, Li H, Ho AK, Sanders H, Sferruzza A, Jones D, Waldman F. (2012) Detection of BRAF mutations in melanoma: rate of mutation detection at codon 600 using Sanger sequencing as compared to the Cobas 4800 method. J Clin Oncol 30(suppl; abstr 8596). American Society of Clinical Oncology Meeting, June 4. Chicago, IL.
Dai Z, Kelly JC, Meloni-Ehrig A, Slovak ML, Boles D, Christacos NC, Schonberg SA; Otani JA, Pan Q, Ho AK, Jones DM, Mowrey PN. (2012) Incidence and patterns of ALK FISH abnormalities seen a large series of lung carcinomas. American College of Medical Genetics Meeting, Poster Presentation, March 29. Charlotte, NC.
Spence DC, Duncavage E, Tripp S, Ho AK, Perkins S. (2011) CCR7 expression is not a useful clinical marker for CNS involvement in T lymphoblastic leukemia/lymphoma. Modern Pathology 24(S1):323A.
Schumacher JA, Szankasi P, Ho AK, Kelley TW. (2010) A pyrosequencing-based test for quantitative monitoring of the BCR-ABL T315I mutation. Journal of Molecular Diagnostics 12(6):869.
Schumacher JA, Salama ME, Szankasi P, Ho AK, Kelley TW. (2010) Isolation of high-quality miRNA from decalcified, formalin-fixed, paraffin-embedded bone marrow biopsy samples. Modern Pathology 23(S1):428A.
Szankasi P, Ho AK, Kelley TW. (2009) Detection of C-KIT mutations in acute myeloid leukemia. Journal of Molecular Diagnostics 11(6):630.
Patel JL, Ho AK, Bahler DW. (2009) Aberrant expression of T-cell antigens in diffuse large B-cell lymphoma of the testis. Archives of Pathology and Laboratory Medicine 133(10): 1650.
Salama ME, Ho AK, Perkins SL, Tward JD, Gaffney DK, Mariappan RM. (2008) BCL2 expression in primary cutaneous follicle center lymphoma: clinicopathologic study of 15 cases. Modern Pathology 21(S1):101A.
Ho AK, Hill S, Preobrazhensky SN, Chen Z, and Bahler DW. (2007) Cases with typical mantle cell lymphoma immunophenotypes by flow cytometry often include chronic lymphocytic leukemias. Modern Pathology 20(S2):244A.